Compare BridgeBio Pharma Inc (BBIO) vs Amplify Cybersecurity ETF (HACK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Amplify Cybersecurity ETF — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Amplify Cybersecurity ETF trades at $114.39. The key difference: Amplify Cybersecurity ETF is trading nearer its 52-week high, BridgeBio Pharma Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | HACK | |
|---|---|---|
Market Cap | $16.27B | — |
Sector | Health | Sector/Thematic |
52-Week High | $90.17 | $114.29 |
52-Week Low | $44.81 | $70.69 |
Enterprise Value | $17.82B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Amplify Cybersecurity ETF
HACK provides diversified exposure to the global cybersecurity industry. It invests across the full value chain, including hardware, software, and consulting services, with key holdings in firms like Broadcom, Cisco, and Palo Alto Networks.
Read more on HACK →
